Hemin treatment induced the ubiquitin-dependent degradation of BACH1 protein, reprogrammed cancer metabolism, and generated cancer vulnerability against mitochondrial oxidative phosphorylation inhibitors. The gene discussed is BACH1; the disease is cancer.